We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Rising Sales & Declining Cash Flows: The Aflac Investor Dilemma
Read MoreHide Full Article
Key Takeaways
Aflac sales rose 18.7% in Japan and 3.1% in the United States in the first half of the year.
Cost discipline supported a 22.5% U.S. pretax margin in the second quarter.
Operating cash flow fell for four straight years, down 10.5% in early 2025.
Aflac Incorporated (AFL - Free Report) is well-poised for growth on the back of expanding sales in both Japan and the United States, a trusted brand, innovative product offerings, strict underwriting discipline and effective cost management. The company’s stability, defensive business model and consistent capital deployment strategy remain major positives. Headquartered in Columbus, Aflac distributes its supplemental health and life insurance products through a wide network of brokers, banks, employers and corporate agencies.
Let’s take a closer look.
Aflac’s Rising Sales Momentum
The company’s sales in the Japan segment witnessed 18.7% year-over-year growth in the first half of the year to $236 million. Solid sales of Miraito and efforts to reach younger customers with the first sector product, Tsumitasu, will further boost the figures. U.S. sales climbed 3.1% year over year to $649 million during the same period, with group life and disability products playing a key role in supporting the momentum.
Margin Strength
Higher premiums, disciplined underwriting and efficiency gains are expected to keep margins resilient. For 2025, the company projects pretax margins of 30-33% in Japan and 17-20% in the United States. Notably, the U.S. segment posted a 22.5% pretax margin in the second quarter, underscoring the impact of its cost-control measures.
Resilient Core Business
Demand for supplemental insurance remains robust as these products fill coverage gaps rather than compete with traditional offerings. This specialization provides Aflac with a relatively defensive revenue stream that is less vulnerable to economic swings.
Shareholder Value Boosting Efforts
Shareholder rewards remain a priority for the company. In the second quarter alone, Aflac repurchased 7.9 million shares worth $829 million. In August, it authorized an additional 100 million shares for repurchase, bringing the total remaining authorization to roughly 130.9 million shares. The company also extended its dividend growth streak to 42 consecutive years in 2024. Overall, capital deployment reached $2.4 billion in the first half of 2025.
AFL’s Earnings Surprise History
Aflac’s earnings have outpaced the Zacks Consensus Estimate in two of the trailing four quarters and missed twice, the average surprise being 6.6%.
Key Concerns
Despite its strengths, there are challenges to monitor. Operating cash flow has been in steady decline, down 15.2% in 2021, 23.2% in 2022, 17.8% in 2023, 15.1% in 2024 and another 10.5% in the first half of 2025. This ongoing trend could limit the company’s flexibility to pursue growth investments. Net earned premiums have also declined for four consecutive years, highlighting business headwinds. Nevertheless, we believe that a systematic and strategic plan of action will drive growth in the long term.
How Are AFL’s Peers Performing
Several competitors, such as AMERISAFE, Inc. (AMSF - Free Report) and Globe Life Inc. (GL - Free Report) , are also making moves. AMERISAFE has carved out a niche in workers’ compensation for high-hazard industries, maintaining a strong voluntary retention rate of 93.8%. It also maintains a robust, debt-free balance sheet, offering significant financial flexibility for operations. However, AMSF’s operating cash flow has been inconsistent, with declines in four of the past five years.
Globe Life offers life and supplemental health coverage in the domestic market, benefiting from its American Income distribution channel. Premium income and underwriting margins have grown steadily, while net investment income witnessed a 6% CAGR over the past three years. On the downside, Globe Life’s rising expenses and elevated debt levels remain concerns.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Rising Sales & Declining Cash Flows: The Aflac Investor Dilemma
Key Takeaways
Aflac Incorporated (AFL - Free Report) is well-poised for growth on the back of expanding sales in both Japan and the United States, a trusted brand, innovative product offerings, strict underwriting discipline and effective cost management. The company’s stability, defensive business model and consistent capital deployment strategy remain major positives. Headquartered in Columbus, Aflac distributes its supplemental health and life insurance products through a wide network of brokers, banks, employers and corporate agencies.
Let’s take a closer look.
Aflac’s Rising Sales Momentum
The company’s sales in the Japan segment witnessed 18.7% year-over-year growth in the first half of the year to $236 million. Solid sales of Miraito and efforts to reach younger customers with the first sector product, Tsumitasu, will further boost the figures. U.S. sales climbed 3.1% year over year to $649 million during the same period, with group life and disability products playing a key role in supporting the momentum.
Margin Strength
Higher premiums, disciplined underwriting and efficiency gains are expected to keep margins resilient. For 2025, the company projects pretax margins of 30-33% in Japan and 17-20% in the United States. Notably, the U.S. segment posted a 22.5% pretax margin in the second quarter, underscoring the impact of its cost-control measures.
Resilient Core Business
Demand for supplemental insurance remains robust as these products fill coverage gaps rather than compete with traditional offerings. This specialization provides Aflac with a relatively defensive revenue stream that is less vulnerable to economic swings.
Shareholder Value Boosting Efforts
Shareholder rewards remain a priority for the company. In the second quarter alone, Aflac repurchased 7.9 million shares worth $829 million. In August, it authorized an additional 100 million shares for repurchase, bringing the total remaining authorization to roughly 130.9 million shares. The company also extended its dividend growth streak to 42 consecutive years in 2024. Overall, capital deployment reached $2.4 billion in the first half of 2025.
AFL’s Earnings Surprise History
Aflac’s earnings have outpaced the Zacks Consensus Estimate in two of the trailing four quarters and missed twice, the average surprise being 6.6%.
Key Concerns
Despite its strengths, there are challenges to monitor. Operating cash flow has been in steady decline, down 15.2% in 2021, 23.2% in 2022, 17.8% in 2023, 15.1% in 2024 and another 10.5% in the first half of 2025. This ongoing trend could limit the company’s flexibility to pursue growth investments. Net earned premiums have also declined for four consecutive years, highlighting business headwinds. Nevertheless, we believe that a systematic and strategic plan of action will drive growth in the long term.
How Are AFL’s Peers Performing
Several competitors, such as AMERISAFE, Inc. (AMSF - Free Report) and Globe Life Inc. (GL - Free Report) , are also making moves. AMERISAFE has carved out a niche in workers’ compensation for high-hazard industries, maintaining a strong voluntary retention rate of 93.8%. It also maintains a robust, debt-free balance sheet, offering significant financial flexibility for operations. However, AMSF’s operating cash flow has been inconsistent, with declines in four of the past five years.
Globe Life offers life and supplemental health coverage in the domestic market, benefiting from its American Income distribution channel. Premium income and underwriting margins have grown steadily, while net investment income witnessed a 6% CAGR over the past three years. On the downside, Globe Life’s rising expenses and elevated debt levels remain concerns.